GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP3, FABP4, FLT3, HMGCR, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, POLB, PPARA, SMAD3, SRC, TEK, TYR |
10.3522 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP3, HMGCR, HSD17B2, IGF1R, INSR, MMP2, MMP9, POLB, PPARA, SRC, TEK, TYR |
10.0443 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP3, FABP4, FLT3, HMGCR, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, POLB, PPARA, SMAD3, SRC, TEK, TYR |
8.95576 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, ALOX5, ALPI, ALPL, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DUSP3, EGFR, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B1, HSD17B2, HSPA1A, HTR1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, SMAD3, SRC, TBXAS1, TEK, TOP2A, TYR, XDH |
8.65075 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, ALOX5, ALPI, ALPL, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DUSP3, EGFR, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B1, HSD17B2, HSPA1A, HTR1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, NUAK1, PIM1, POLA1, POLB, PPARA, SMAD3, SRC, TBXAS1, TEK, TOP2A, TYR, XDH |
8.3005 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, AKR1B1, APEX1, AURKB, AXL, BCL2, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DRD2, EGFR, FABP3, FABP4, FLT3, GPR35, HMGCR, HSD17B1, HSD17B2, HSPA1A, HTR1A, INSR, KDR, MET, POLA1, POLB, PPARA, SMAD3, SRC, TEK, XDH |
8.18255 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APEX1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP4, KDR, MMP9, SRC |
7.24343 |
[BP] GO:0042127 |
regulation of cell proliferation
|
AKR1B1, BCL2, CSNK2A1, CYP1B1, DRD2, EGFR, FABP3, FLT3, HMGCR, HSPA1A, HTR1A, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, NUAK1, PIM1, SMAD3, SRC, TEK, XDH |
7.24343 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.24343 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, FLT3, GLO1, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PPARA, SMAD3, SRC, TEK, TOP2A, XDH |
7.24343 |
[BP] GO:0010647 |
positive regulation of cell communication
|
AKR1B1, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, EGFR, FLT3, GPR35, HMGCR, HSPA1A, INSR, KDR, MET, MMP12, MMP9, SMAD3, SRC, TEK, XDH |
7.2324 |
[BP] GO:0023056 |
positive regulation of signaling
|
AKR1B1, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, EGFR, FLT3, GPR35, HMGCR, HSPA1A, INSR, KDR, MET, MMP12, MMP9, SMAD3, SRC, TEK, XDH |
7.22005 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, ALOX5, ALPI, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP3, FABP4, FUT7, HMGCR, HSD17B1, HSD17B2, MET, PPARA, TBXAS1 |
7.13941 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, FLT3, GLO1, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, SMAD3, SRC, TEK, TOP2A, XDH |
7.11916 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DUSP3, EGFR, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B2, INSR, KDR, MET, MMP2, MMP9, PIM1, POLB, PPARA, SMAD3, SRC, TEK, TOP2A, TYR |
7.07785 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PPARA, SMAD3, SRC, TEK |
7.05297 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, SMAD3, SRC, TEK |
6.87308 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, SMAD3, SRC, TEK |
6.7896 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, SRC, TEK |
6.7896 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPI, ALPL, APEX1, AURKB, AXL, BCL2, CSNK2A1, DRD2, DUSP3, EGFR, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, POLB, SRC, TEK, XDH |
6.7896 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, FABP3, FLT3, INSR, PPARA, SRC, TEK |
6.5849 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, FLT3, HSD17B2, INSR, KDR, POLB, PPARA, SMAD3, SRC, TEK, TYR |
6.56054 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, AKR1B1, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CHRM2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP3, FABP4, FLT3, HMGCR, HSD17B2, HSPA1A, HTR1A, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, NUAK1, POLA1, POLB, PPARA, SMAD3, SRC, TEK, TOP2A, TYR |
6.54424 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, FLT3, GLO1, HMGCR, HSPA1A, IGF1R, KDR, MMP9, PIM1, SMAD3, SRC, TEK, TOP2A, XDH |
6.54424 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPI, ALPL, APEX1, AURKB, AXL, BCL2, CSNK2A1, DRD2, DUSP3, EGFR, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, POLB, SRC, TEK, XDH |
6.45905 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, ALOX5, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FUT7, GLO1, HMGCR, HSPA1A, PIM1, PPARA, TBXAS1, TYR, XDH |
6.36137 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
6.3276 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1B1, DRD2, HMGCR, KDR, POLB, SRC |
6.11616 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPI, ALPL, AURKB, AXL, BCL2, CSNK2A1, CYP1A1, CYP1A2, DRD2, DUSP3, EGFR, FLT3, FUT7, GLO1, HMGCR, HSPA1A, HTR1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, POLB, PPARA, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
6.11584 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FLT3, SRC, TEK, TYR |
6.11584 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, HMGCR, HSPA1A, IGF1R, KDR, MMP9, PIM1, SMAD3, SRC, TEK |
6.09705 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, AKR1B1, APEX1, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD2, DUSP3, EGFR, FABP3, FLT3, GPR35, HMGCR, HSPA1A, HTR1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SMAD3, SRC, TEK, TOP2A, XDH |
6.07733 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DUSP3, EGFR, FLT3, GPR35, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, SRC, TEK, XDH |
5.95933 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CSNK2A1, DRD2, EGFR, FLT3, HMGCR, HTR1A, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, PIM1, TEK |
5.92176 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, POLA1, POLB, SMAD3, SRC, TOP2A |
5.865 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.865 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.81291 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
AKR1B1, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, EGFR, FLT3, GPR35, HMGCR, HSPA1A, INSR, KDR, MET, MMP12, MMP9, SMAD3, SRC, TEK, XDH |
5.80673 |
[BP] GO:0042592 |
homeostatic process
|
AKR1B1, APEX1, AXL, BCL2, CA12, CA2, CA7, DRD2, EGFR, FABP3, FABP4, FLT3, GPR35, INSR, MET, POLA1, POLB, SMAD3, SRC |
5.76131 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DUSP3, EGFR, FLT3, GPR35, HMGCR, HSPA1A, HTR1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, SMAD3, SRC, TEK, XDH |
5.64965 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DUSP3, EGFR, FLT3, GPR35, HMGCR, HSPA1A, HTR1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, SMAD3, SRC, TEK, XDH |
5.53431 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
5.52873 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, ALOX5, ALPI, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP3, FABP4, FUT7, HMGCR, MET, PPARA, TBXAS1 |
5.46489 |
[BP] GO:0032501 |
multicellular organismal process
|
AKR1B1, ALOX5, ALPI, ALPL, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, DRD2, DUSP3, EGFR, FABP4, HMGCR, HSD17B2, HTR1A, IGF1R, INSR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SMAD3, SRC, TEK, TYR |
5.44534 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
AKR1B1, AXL, BCL2, CYP1B1, DRD2, EGFR, FLT3, GPR35, HMGCR, HSPA1A, INSR, KDR, MET, SRC, TEK, XDH |
5.40462 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, FABP3, FLT3, HSD17B2, SRC, TYR |
5.33186 |
[BP] GO:0009628 |
response to abiotic stimulus
|
AKR1B1, AURKB, BCL2, CA2, CYP1A1, DRD2, EGFR, HMGCR, HSPA1A, MMP2, POLB, PPARA, SMAD3, SRC, TEK, TYR |
5.25296 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, AKR1B1, APEX1, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD2, DUSP3, EGFR, FABP3, FABP4, FLT3, GPR35, HMGCR, HSPA1A, HTR1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SMAD3, SRC, TEK, TOP2A, XDH |
5.25078 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, BCL2, CA9, CYP1A1, CYP1B1, DRD2, EGFR, FABP3, HMGCR, KDR, POLB, SRC |
5.24123 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, APEX1, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, EGFR, GPR35, HMGCR, HSPA1A, HTR1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, PPARA, SMAD3, SRC, TEK |
5.23978 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, SMAD3, SRC |
5.23043 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, MMP9, SRC |
5.05487 |
[BP] GO:0030334 |
regulation of cell migration
|
APEX1, BCL2, CYP19A1, CYP1B1, DRD2, EGFR, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
5.00864 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CYP1A1, EGFR, FLT3, HTR1A, MET, PIM1, POLA1, SRC, TEK, TYR |
4.95847 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, EGFR, MMP9, SRC |
4.9414 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, AKR1B1, ALOX5, ALPI, ALPL, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DUSP3, EGFR, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, SMAD3, SRC, TBXAS1, TEK, TOP2A, TYR, XDH |
4.90486 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, ALPL, AXL, BCL2, CA2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DUSP3, EGFR, FLT3, HSD17B2, INSR, KDR, MMP9, PIM1, POLB, PPARA, SMAD3, SRC, TEK, TYR |
4.87516 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, ALOX5, ALPI, ALPL, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DUSP3, EGFR, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B1, HSD17B2, HSPA1A, HTR1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, SMAD3, SRC, TBXAS1, TEK, TOP2A, TYR, XDH |
4.87516 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
AKR1B1, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, EGFR, FABP4, FLT3, GPR35, HMGCR, HSPA1A, INSR, KDR, MET, MMP12, MMP2, MMP9, SMAD3, SRC, TEK, XDH |
4.75393 |
[BP] GO:2000145 |
regulation of cell motility
|
APEX1, BCL2, CYP19A1, CYP1B1, DRD2, EGFR, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
4.71941 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
4.61722 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.58411 |
[BP] GO:0070482 |
response to oxygen levels
|
BCL2, CYP1A1, DRD2, MMP2, POLB, PPARA, SMAD3, SRC, TEK |
4.40689 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, SRC, TEK |
4.36958 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, EGFR, INSR, MET, SRC, TEK, XDH |
4.36958 |
[BP] GO:0040012 |
regulation of locomotion
|
APEX1, BCL2, CYP19A1, CYP1B1, DRD2, EGFR, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
4.3402 |
[BP] GO:0051270 |
regulation of cellular component movement
|
APEX1, BCL2, CYP19A1, CYP1B1, DRD2, EGFR, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
4.3276 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, DRD2, EGFR, HMGCR, HSD17B1, HSD17B2, HTR1A |
4.3021 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, DRD2, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, SRC, TEK, TYR |
4.29755 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1B1, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, MMP2, SMAD3, SRC |
4.26226 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
4.22903 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, FABP3, PPARA |
4.14472 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, BCL2, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
4.119 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
4.07995 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, SMAD3, SRC, TEK |
4.0269 |
[BP] GO:0080134 |
regulation of response to stress
|
CYP19A1, DRD2, DUSP3, EGFR, FABP4, HMGCR, HSPA1A, IGF1R, MET, MMP12, MMP2, NUAK1, PPARA, SMAD3, SRC, TEK, XDH |
3.96815 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, DRD2, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, SRC, TEK, TYR |
3.96815 |
[BP] GO:0030335 |
positive regulation of cell migration
|
BCL2, EGFR, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
3.95953 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HMGCR, HSD17B1, HSD17B2 |
3.93095 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
3.9071 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.86554 |
[BP] GO:2000147 |
positive regulation of cell motility
|
BCL2, EGFR, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
3.85029 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, SRC |
3.85029 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 |
3.85029 |
[BP] GO:0006950 |
response to stress
|
ACHE, AKR1B1, APEX1, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, HSPA1A, HTR1A, MMP2, MMP9, NUAK1, POLA1, POLB, PPARA, SMAD3, SRC, TEK, TOP2A |
3.81765 |
[BP] GO:0001666 |
response to hypoxia
|
BCL2, CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK |
3.81244 |
[BP] GO:0009611 |
response to wounding
|
ACHE, BCL2, CYP1A1, DRD2, EGFR, PPARA, SMAD3 |
3.78684 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
BCL2, EGFR, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
3.76253 |
[BP] GO:0001503 |
ossification
|
ALPL, BCL2, EGFR, MMP2, MMP9, TEK |
3.73969 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
BCL2, CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK |
3.73651 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK, TOP2A |
3.71416 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 |
3.71379 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
BCL2, DRD2, DUSP3, EGFR, FABP3, FABP4, FLT3, HMGCR, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, SMAD3, SRC, TEK, XDH |
3.70204 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
BCL2, DRD2, DUSP3, EGFR, FABP3, FABP4, FLT3, HMGCR, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, SMAD3, SRC, TEK, XDH |
3.65874 |
[BP] GO:0040017 |
positive regulation of locomotion
|
BCL2, EGFR, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
3.65716 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, ALOX5, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HMGCR, HSD17B1, HSD17B2, TBXAS1, TYR, XDH |
3.63787 |
[BP] GO:0048583 |
regulation of response to stimulus
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD2, DUSP3, EGFR, FABP4, FLT3, GPR35, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP2, MMP9, NUAK1, PPARA, SMAD3, SRC, TEK, XDH |
3.57253 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD2, EGFR, PPARA, SRC, TOP2A |
3.56869 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD2, DUSP3, EGFR, FABP3, FABP4, GLO1, GPR35, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, SMAD3, SRC, TEK, TOP2A, XDH |
3.56123 |
[BP] GO:0009966 |
regulation of signal transduction
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DUSP3, EGFR, FLT3, GPR35, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, SMAD3, SRC, TEK, XDH |
3.54539 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DRD2, DUSP3, HMGCR, HSPA1A, IGF1R, MET, MMP9, SRC, XDH |
3.46327 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, BCL2, CA12, CA2, CA7, DRD2, EGFR, FABP3, FABP4, GPR35, INSR, MET, SMAD3 |
3.41598 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APEX1, AURKB, BCL2, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, TOP2A |
3.38411 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, BCL2, DRD2, DUSP3, EGFR, GPR35, HMGCR, HSPA1A, IGF1R, MET, MMP12, MMP9, SMAD3, SRC, XDH |
3.3833 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, BCL2, DRD2, DUSP3, EGFR, GPR35, HMGCR, HSPA1A, IGF1R, MET, MMP12, MMP9, SMAD3, SRC, XDH |
3.36988 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, HMGCR, MMP2, MMP9 |
3.36258 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, BCL2, CYP19A1, CYP1A1, CYP1B1, DRD2, HMGCR, HTR1A, TYR |
3.36258 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.36258 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, AXL, BCL2, CA2, CA7, CYP19A1, DRD2, EGFR, GPR35, HMGCR, HSPA1A, HTR1A, INSR, MMP12, MMP9, PPARA, SMAD3, SRC |
3.35549 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD2, HTR1A, TYR |
3.3216 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
BCL2, CYP19A1, DRD2, DUSP3, EGFR, HMGCR, HSPA1A, IGF1R, MET, MMP12, MMP9, PPARA, SMAD3, SRC, TEK, XDH |
3.31704 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, FABP3, PPARA |
3.30069 |
[BP] GO:0010038 |
response to metal ion
|
BCL2, CA2, CYP1A1, CYP1A2, DRD2, EGFR, FABP4, MMP9 |
3.25935 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, BCL2, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.24725 |
[BP] GO:0051726 |
regulation of cell cycle
|
APEX1, AURKB, BCL2, CSNK2A1, CYP1A1, DRD2, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, SRC, TOP2A |
3.19247 |
[BP] GO:0044092 |
negative regulation of molecular function
|
AURKB, CSNK2A1, CYP1B1, DRD2, DUSP3, FABP4, GPR35, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, SRC |
3.19247 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
AURKB, AXL, BCL2, DRD2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, SMAD3, SRC, TEK |
3.17394 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
AXL, BCL2, CA2, CYP1B1, DRD2, EGFR, HMGCR, HSPA1A, KDR, MET, MMP12, MMP9, PIM1, SMAD3, SRC, TEK |
3.1687 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, INSR, MET, SRC, TEK |
3.14077 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
DRD2, DUSP3, EGFR, FLT3, HMGCR, IGF1R, INSR, KDR, SRC, TEK, XDH |
3.095 |
[BP] GO:0048732 |
gland development
|
BCL2, CSNK2A1, CYP19A1, EGFR, INSR, SMAD3, TYR |
3.06643 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
3.04448 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, FABP3, IGF1R, INSR, PPARA, SRC, TEK |
3.01329 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
3.00415 |
[BP] GO:0006286 |
base-excision repair, base-free sugar-phosphate removal
|
APEX1, POLB |
2.95105 |
[BP] GO:0032844 |
regulation of homeostatic process
|
AURKB, BCL2, CA2, CA7, DRD2, EGFR, HMGCR, KDR, SRC |
2.95105 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD2, EGFR, HTR1A, INSR, SMAD3 |
2.93906 |
[BP] GO:0048534 |
hematopoietic or lymphoid organ development
|
BCL2, FLT3, KDR, POLB, TEK, TYR |
2.93906 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, TBXAS1 |
2.92642 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
BCL2, CYP1B1, EGFR, INSR, SMAD3, XDH |
2.91476 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
AURKB, BCL2, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
2.90301 |
[BP] GO:0031348 |
negative regulation of defense response
|
CYP19A1, DRD2, MMP12, PPARA, SMAD3, TEK |
2.89078 |
[BP] GO:0009056 |
catabolic process
|
ACHE, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, HSPA1A, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
2.86943 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APEX1, AURKB, CYP1A1, DRD2, DUSP3, EGFR, INSR, SRC |
2.86373 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.86373 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.86373 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, MET, SRC |
2.86373 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, MET, SRC |
2.86373 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.84534 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ALPI, ALPL, AURKB, AXL, BCL2, CSNK2A1, DUSP3, EGFR, FLT3, FUT7, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, POLB, PPARA, SMAD3, SRC, TEK, TOP2A |
2.83787 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
BCL2, KDR, SMAD3, SRC, TEK |
2.82962 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
BCL2, DRD2, EGFR, FABP3, FLT3, HMGCR, INSR, KDR, MMP9, SMAD3, SRC, TEK, XDH |
2.82264 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
BCL2, DRD2, EGFR, FABP3, FLT3, HMGCR, INSR, KDR, MMP9, SMAD3, SRC, TEK, XDH |
2.82264 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, TBXAS1 |
2.81648 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
CYP19A1, DRD2, EGFR, FABP4, HMGCR, KDR, MET, MMP12, PPARA, SMAD3, TEK |
2.80552 |
[BP] GO:0031347 |
regulation of defense response
|
CYP19A1, DRD2, EGFR, FABP4, HSPA1A, MMP12, MMP2, PPARA, SMAD3, SRC, TEK |
2.78985 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
DRD2, DUSP3, EGFR, HMGCR, KDR, SRC, TEK |
2.78985 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
DRD2, EGFR, FLT3, HMGCR, INSR, KDR, SRC, TEK, XDH |
2.75818 |
[BP] GO:0009987 |
cellular process
|
ACHE, AKR1B1, ALOX5, ALPI, ALPL, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DUSP3, EGFR, FABP3, FABP4, FLT3, FUT7, GLO1, GPR35, HMGCR, HSD17B1, HSD17B2, HSPA1A, HTR1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, SMAD3, SRC, TBXAS1, TEK, TOP2A, TYR, XDH |
2.71848 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
BCL2, CA2, CA9, EGFR, MET, SMAD3, SRC |
2.71848 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, KDR, SRC |
2.71848 |
[BP] GO:0042325 |
regulation of phosphorylation
|
BCL2, DRD2, DUSP3, EGFR, FABP4, FLT3, HMGCR, IGF1R, INSR, KDR, MMP9, PPARA, SRC, TEK, XDH |
2.70056 |
[BP] GO:0009653 |
anatomical structure morphogenesis
|
AXL, BCL2, CA2, CA9, CYP1B1, DRD2, EGFR, INSR, MET, MMP2, POLB, SMAD3, SRC, TEK |
2.6949 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.6949 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, TBXAS1 |
2.6949 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.6949 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALPI, CSNK2A1, DRD2, EGFR, FABP3, FABP4, MET |
2.64956 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD2, DUSP3, EGFR, FABP3, FABP4, GLO1, GPR35, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, SMAD3, SRC, TEK, TOP2A, XDH |
2.64879 |
[BP] GO:0033554 |
cellular response to stress
|
AKR1B1, APEX1, AXL, BCL2, CA2, CA9, CYP1B1, EGFR, HSPA1A, MMP9, NUAK1, POLA1, POLB, SRC, TOP2A |
2.6462 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.62562 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
DRD2, EGFR, HMGCR, KDR, SRC, TEK |
2.61762 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.61652 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA, TBXAS1 |
2.61437 |
[BP] GO:0016477 |
cell migration
|
AXL, CYP1B1, DRD2, EGFR, FUT7, KDR, MMP1, MMP12, MMP9, SRC, TEK |
2.59651 |
[BP] GO:0098502 |
DNA dephosphorylation
|
APEX1, POLB |
2.58075 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.58075 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR |
2.57389 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
BCL2, DRD2, DUSP3, EGFR, HMGCR, HSPA1A, IGF1R, MET, MMP12, MMP9, SMAD3, SRC, XDH |
2.55356 |
[BP] GO:0065009 |
regulation of molecular function
|
AURKB, BCL2, CSNK2A1, CYP1B1, DRD2, DUSP3, EGFR, FABP4, FLT3, GPR35, HMGCR, HSPA1A, IGF1R, INSR, MET, MMP9, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, XDH |
2.55356 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, AXL, BCL2, CYP1A1, DRD2, EGFR, FABP4, FLT3, FUT7, GLO1, HMGCR, KDR, MET, MMP2, MMP9, SMAD3, SRC, TEK, TOP2A |
2.55133 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALPI, CSNK2A1, CYP19A1, CYP1A1, HMGCR, HSD17B1, HSD17B2 |
2.54354 |
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, BCL2, MET, MMP9, PPARA, SRC |
2.54354 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, SRC, TEK |
2.53583 |
[BP] GO:0031399 |
regulation of protein modification process
|
BCL2, DRD2, DUSP3, EGFR, FABP4, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, SRC, TEK, XDH |
2.53583 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
BCL2, DRD2, DUSP3, EGFR, FABP4, FLT3, HMGCR, IGF1R, INSR, KDR, MMP9, SRC, TEK, XDH |
2.53057 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.53057 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2 |
2.53057 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.52748 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
BCL2, CA2, CA7, DRD2, KDR, SRC |
2.52229 |
[BP] GO:0040011 |
locomotion
|
AXL, CYP1B1, DRD2, EGFR, FUT7, KDR, MET, MMP1, MMP12, MMP9, SRC, TEK |
2.52102 |
[BP] GO:0051704 |
multi-organism process
|
AXL, BCL2, CHRM2, CYP1A1, EGFR, HSPA1A, INSR, KDR, MET, MMP1, MMP12, POLA1, SMAD3, SRC |
2.52102 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, EGFR, HMGCR |
2.52102 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, SRC, TEK |
2.52102 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HMGCR, HSD17B1, HSD17B2 |
2.50634 |
[BP] GO:0006807 |
nitrogen compound metabolic process
|
ACHE, AKR1B1, ALPI, ALPL, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DUSP3, EGFR, FLT3, FUT7, GLO1, HMGCR, HSPA1A, HTR1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
2.50515 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, BCL2, CYP1A1, EGFR, HMGCR, SRC, TYR |
2.50177 |
[BP] GO:0022612 |
gland morphogenesis
|
BCL2, EGFR, POLB |
2.48427 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, HMGCR, MMP2, MMP9 |
2.48313 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.44851 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, EGFR, FABP3, HSD17B2, KDR, MMP2, SRC |
2.43931 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.43393 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, EGFR, FLT3, SRC |
2.42591 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.38609 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.38609 |
[BP] GO:0031099 |
regeneration
|
AXL, BCL2, CSNK2A1, EGFR, FLT3 |
2.37754 |
[BP] GO:0042180 |
None
|
AKR1B1, CYP19A1, GLO1, HMGCR |
2.36458 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.35079 |
[BP] GO:0050790 |
regulation of catalytic activity
|
AURKB, BCL2, CSNK2A1, DRD2, DUSP3, EGFR, FABP4, FLT3, HMGCR, HSPA1A, IGF1R, INSR, MMP9, NUAK1, SMAD3, SRC, TEK, XDH |
2.3218 |
[BP] GO:0007568 |
aging
|
APEX1, AURKB, BCL2, CYP1A1, HMGCR, POLB |
2.31624 |
[BP] GO:0044419 |
interspecies interaction between organisms
|
AXL, EGFR, HSPA1A, INSR, KDR, MET, MMP1, POLA1, SMAD3, SRC |
2.31624 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
DUSP3, EGFR, FLT3, HMGCR, IGF1R, INSR, SRC |
2.31541 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, IGF1R, INSR, MMP2, MMP9, SRC |
2.31496 |
[BP] GO:0048870 |
cell motility
|
AXL, CYP1B1, DRD2, EGFR, FUT7, KDR, MMP1, MMP12, MMP9, SRC, TEK |
2.30659 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
2.30606 |
[BP] GO:0044267 |
cellular protein metabolic process
|
ALPI, ALPL, AURKB, AXL, BCL2, CSNK2A1, DUSP3, EGFR, FLT3, FUT7, IGF1R, INSR, KDR, MET, MMP1, MMP2, NUAK1, PIM1, POLB, SMAD3, SRC, TEK, TOP2A |
2.30454 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.30231 |
[BP] GO:0051098 |
regulation of binding
|
AURKB, BCL2, MET, MMP9, PPARA, SMAD3, SRC |
2.30187 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.28947 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APEX1, CYP1A1, CYP1B1, EGFR, FLT3, SRC |
2.24236 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, PPARA, TBXAS1 |
2.23829 |
[BP] GO:0071248 |
cellular response to metal ion
|
CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.23087 |
[BP] GO:0031100 |
animal organ regeneration
|
AXL, CSNK2A1, EGFR, FLT3 |
2.22769 |
[BP] GO:0048729 |
tissue morphogenesis
|
BCL2, CA2, CA9, EGFR, MET, SMAD3, SRC |
2.2183 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
BCL2, DRD2, EGFR, FLT3, HMGCR, INSR, KDR, MMP9, SRC, TEK, XDH |
2.20416 |
[BP] GO:0022617 |
extracellular matrix disassembly
|
MMP1, MMP12, MMP2, MMP9 |
2.17029 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
CYP1A1, FABP3, FLT3, HMGCR, PPARA, SRC, TEK |
2.16934 |
[BP] GO:0098501 |
polynucleotide dephosphorylation
|
APEX1, POLB |
2.16934 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, EGFR, FLT3, SRC |
2.15582 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, TBXAS1 |
2.15582 |
[BP] GO:0003018 |
None
|
EGFR, HMGCR, HTR1A, SRC, TEK |
2.15582 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, AXL, BCL2, CA2, CYP19A1, DRD2, EGFR, INSR, MMP12, SMAD3, SRC |
2.15165 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
AXL, BCL2, CA1, CSNK2A1, DRD2, EGFR, FLT3, GPR35, IGF1R, INSR, KDR, MET, MMP2, MMP9, SMAD3, SRC, TEK |
2.14955 |
[BP] GO:0035556 |
intracellular signal transduction
|
AKR1B1, AXL, BCL2, CYP1B1, DRD2, EGFR, IGF1R, INSR, KDR, MET, NUAK1, POLB, SRC, TEK |
2.14955 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, SRC, TEK |
2.14955 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR |
2.14955 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
AXL, BCL2, CA2, CHRM2, CYP1B1, DRD2, EGFR, GPR35, HMGCR, HSPA1A, INSR, KDR, MET, MMP12, MMP9, PIM1, SMAD3, SRC, TEK, XDH |
2.14955 |
[BP] GO:0032963 |
collagen metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.149 |
[BP] GO:0045927 |
positive regulation of growth
|
BCL2, CSNK2A1, DRD2, EGFR, INSR, PIM1 |
2.13451 |
[BP] GO:0033273 |
response to vitamin
|
ALPL, CYP1A1, EGFR, TYR |
2.13451 |
[BP] GO:1901888 |
regulation of cell junction assembly
|
KDR, SMAD3, SRC, TEK |
2.13451 |
[BP] GO:1901890 |
None
|
KDR, SMAD3, TEK |
2.11978 |
[BP] GO:0071276 |
cellular response to cadmium ion
|
CYP1A2, EGFR, MMP9 |
2.11978 |
[BP] GO:0010039 |
response to iron ion
|
BCL2, CYP1A1, DRD2 |
2.11978 |
[BP] GO:0002521 |
leukocyte differentiation
|
AXL, BCL2, FLT3, FUT7, GLO1, MMP9 |
2.09032 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, APEX1, AURKB, BCL2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DUSP3, EGFR, FABP3, FABP4, FLT3, GLO1, HMGCR, HSPA1A, HTR1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIM1, POLA1, PPARA, SMAD3, SRC, TEK, TOP2A, XDH |
2.08792 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, AXL, BCL2, CYP19A1, CYP1A1, EGFR, HSD17B2, INSR, MMP2, MMP9, SRC, TOP2A |
2.08762 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
CA2, CA7, DRD2 |
2.0871 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
BCL2, DRD2, EGFR, FLT3, HMGCR, INSR, KDR, MMP9, SRC, TEK, XDH |
2.08024 |
[BP] GO:0044259 |
multicellular organismal macromolecule metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.07083 |
[BP] GO:0090218 |
positive regulation of lipid kinase activity
|
FLT3, SRC, TEK |
2.05261 |
[BP] GO:0010907 |
None
|
INSR, PPARA, SRC |
2.05261 |
[BP] GO:0050801 |
ion homeostasis
|
BCL2, CA12, CA2, CA7, DRD2, EGFR, FABP3, GPR35, SMAD3 |
2.04521 |
[BP] GO:0030155 |
regulation of cell adhesion
|
BCL2, CYP1B1, DUSP3, KDR, NUAK1, PPARA, SMAD3, SRC, TEK |
2.04521 |
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.04521 |
[BP] GO:0043412 |
macromolecule modification
|
ALPI, ALPL, APEX1, AURKB, AXL, BCL2, CSNK2A1, DUSP3, EGFR, FLT3, FUT7, IGF1R, INSR, KDR, MET, NUAK1, PIM1, POLB, SMAD3, SRC, TEK, TOP2A |
2.04097 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
AURKB, BCL2, CSNK2A1, DRD2, EGFR, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, PPARA, SMAD3, SRC, TEK, TOP2A, XDH |
2.04056 |
[BP] GO:0048608 |
reproductive structure development
|
AXL, BCL2, CYP19A1, HSD17B2, INSR, SRC |
2.03506 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, HSPA1A |
2.02013 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
EGFR, INSR, SMAD3, XDH |
2.01475 |
[BP] GO:0051338 |
regulation of transferase activity
|
AURKB, DRD2, DUSP3, EGFR, FABP4, FLT3, HMGCR, IGF1R, INSR, SRC, TEK |
2.00455 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APEX1, EGFR, IGF1R, INSR, MMP2, SRC |
2.00455 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
APEX1, AURKB, BCL2, CA9, CSNK2A1, CYP1A1, CYP1B1, DRD2, DUSP3, EGFR, FABP3, FABP4, FLT3, GLO1, HMGCR, HSPA1A, HTR1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIM1, POLA1, PPARA, SMAD3, SRC, TEK, TOP2A, XDH |
2.00455 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.00385 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD2, EGFR |
2.00188 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APEX1, EGFR, FLT3, IGF1R, INSR, MMP2, SMAD3, SRC |
2.00188 |
[BP] GO:0006464 |
cellular protein modification process
|
ALPI, ALPL, AURKB, AXL, BCL2, CSNK2A1, DUSP3, EGFR, FLT3, FUT7, IGF1R, INSR, KDR, MET, NUAK1, PIM1, POLB, SMAD3, SRC, TEK, TOP2A |
2.00188 |
[BP] GO:0036211 |
protein modification process
|
ALPI, ALPL, AURKB, AXL, BCL2, CSNK2A1, DUSP3, EGFR, FLT3, FUT7, IGF1R, INSR, KDR, MET, NUAK1, PIM1, POLB, SMAD3, SRC, TEK, TOP2A |
2.00188 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ALPI, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CHRM2, CSNK2A1, DRD2, EGFR, FLT3, GLO1, GPR35, HTR1A, IGF1R, INSR, KDR, MET, MMP2, PIM1, SMAD3, SRC, TEK |
2.14724 |
[CC] GO:0016020 |
membrane
|
ACHE, ALOX5, ALPI, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FLT3, FUT7, GLO1, GPR35, HMGCR, HSD17B2, HTR1A, IGF1R, INSR, KDR, MET, MMP2, PIM1, SMAD3, SRC, TBXAS1, TEK, TYR |
2.09038 |
[CC] GO:0016323 |
basolateral plasma membrane
|
CA2, CA4, CA9, EGFR, TEK |
1.88426 |
[CC] GO:0098590 |
plasma membrane region
|
CA2, CA4, CA9, CHRM2, DRD2, EGFR, INSR, MET, SRC, TEK |
1.61091 |
[CC] GO:0048471 |
perinuclear region of cytoplasm
|
ACHE, AKR1B1, APEX1, CA4, EGFR, HSPA1A, SRC, TYR |
1.56617 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPI, ALPL, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP3, FABP4, FLT3, GLO1, HMGCR, HSD17B1, HSPA1A, HTR1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, SMAD3, SRC, TBXAS1, TEK, TOP2A, TYR, XDH |
12.87 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, AKR1B1, ALOX5, ALPI, ALPL, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, FLT3, FUT7, GLO1, HMGCR, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, SRC, TBXAS1, TEK, TOP2A, TYR, XDH |
11.6337 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, ALPI, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, GLO1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SMAD3, TBXAS1, TYR, XDH |
10.3965 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
10.3965 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, POLB |
8.66232 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
7.79282 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
7.13941 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, GLO1, POLB |
6.99066 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, SRC, TEK, TOP2A |
6.99066 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.7896 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPI, ALPL, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, GLO1, HTR1A, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, SMAD3, TBXAS1, TOP2A, TYR, XDH |
6.60361 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.9411 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPI, ALPL, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, GLO1, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, SMAD3, TBXAS1, TOP2A, TYR, XDH |
5.05487 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
4.95982 |
[MF] GO:0008270 |
zinc ion binding
|
ALPI, CA1, CA12, CA2, CA4, CA7, CA9, GLO1, MMP1, MMP12, MMP2, MMP9, PPARA, SMAD3 |
4.78654 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, ALOX5, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HMGCR, HSD17B1, HSD17B2, TBXAS1, TYR, XDH |
4.4724 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, POLA1, POLB, SRC, TEK |
4.4724 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
4.15818 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TBXAS1, TYR |
4.119 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, TBXAS1, XDH |
4.04755 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.93095 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, APEX1, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PIM1, PPARA, SMAD3, SRC |
3.88714 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.80872 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.75553 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, HMGCR, HSD17B1, POLA1, SRC, TBXAS1, XDH |
3.69023 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC, TBXAS1 |
3.49221 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.48367 |
[MF] GO:0036094 |
small molecule binding
|
AURKB, AXL, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, POLA1, SRC, TEK, TOP2A, XDH |
3.48136 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, APEX1, EGFR, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, SMAD3, SRC |
3.41639 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC, TBXAS1 |
3.34469 |
[MF] GO:0000166 |
nucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, POLA1, SRC, TEK, TOP2A, XDH |
3.25584 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, POLA1, SRC, TEK, TOP2A, XDH |
3.25577 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, HSD17B1, IGF1R, INSR |
3.1687 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TBXAS1, TYR |
3.095 |
[MF] GO:0019902 |
phosphatase binding
|
BCL2, EGFR, HMGCR, MET, PPARA, SMAD3 |
2.97069 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.93906 |
[MF] GO:0005524 |
ATP binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A |
2.79165 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A |
2.6949 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A |
2.66652 |
[MF] GO:0005518 |
collagen binding
|
ACHE, MMP12, MMP9, SMAD3 |
2.49464 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.45274 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, BCL2, CSNK2A1, DRD2, EGFR, FLT3, HMGCR, IGF1R, KDR, MET, MMP9, SMAD3, TOP2A, TYR, XDH |
2.3966 |
[MF] GO:0043168 |
anion binding
|
AURKB, AXL, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A, XDH |
2.39565 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, HMGCR, HSD17B1, HSD17B2, XDH |
2.37754 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, CSNK2A1, DUSP3, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, SRC, TEK |
2.20086 |
[MF] GO:0043548 |
phosphatidylinositol 3-kinase binding
|
AXL, IGF1R, INSR |
2.17422 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.16934 |
[MF] GO:0019899 |
enzyme binding
|
ALPI, AURKB, BCL2, CYP1A1, CYP1A2, DUSP3, EGFR, HMGCR, HSPA1A, MET, POLA1, POLB, PPARA, SMAD3, SRC, TEK, TOP2A |
2.11531 |
[MF] GO:0038023 |
signaling receptor activity
|
AXL, CHRM2, DRD2, EGFR, FLT3, GPR35, HTR1A, IGF1R, INSR, KDR, MET, PPARA, TEK |
2.04521 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.04521 |
[MF] GO:0004035 |
alkaline phosphatase activity
|
ALPI, ALPL |
2.04521 |
[MF] GO:0097159 |
organic cyclic compound binding
|
APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FLT3, HMGCR, HSD17B1, HSPA1A, HTR1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PIM1, POLA1, POLB, PPARA, SMAD3, SRC, TBXAS1, TEK, TOP2A, XDH |
2.03506 |